Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 19, 2022
Source ID
10.1021/acschembio.2c00378

Entities

People

  • Alison D Axtman
  • Armin Bayati
  • Boyd L. Yount Jr
  • Carrow Wells
  • Edcon Chang
  • Emily A Madden
  • Erik M. Lenarcic
  • Jason W. Brown
  • Jeffery L. Smith
  • Mark T Heise
  • Nathaniel J. Moorman
  • Peter S McPherson
  • Ralph S. Baric
  • Rebekah J. Dickmander
  • Sharon A. Taft-benz
  • Timothy M Willson
  • Xuan Yang

Organizations

  • Fonds de recherche du Québec
  • McGill University
  • National Institutes of Health
  • Natural Sciences and Engineering Research Council
  • North Carolina Biotechnology Center
  • Parkinson Society Canada
  • Takeda Pharmaceutical Company
  • United States Department of Defense
  • University of North Carolina at Chapel Hill